The global bioabsorbable stents market size is estimated to clock a valuation of US$ 253.9 million by 2033. Our pharmaceutical experts opine that bioabsorbable stent suppliers can expect a CAGR of 4% through 2033, with a present valuation of US$ 171.8 million in 2023.
| Attributes | Details |
|---|---|
| Bioabsorbable Stents Market Size, 2022 | US$ 167.7 million |
| Bioabsorbable Stents Market Size, 2023 | US$ 171.8 million |
| Bioabsorbable Stents Market Size, 2033 | US$ 253.9 million |
| Value CAGR (2023 to 2033) | 4% |
Trend Analysis of Bioabsorbable Stents Market
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Attributes | Details |
|---|---|
| Bioabsorbable Stents Market Size (2018) | US$ 153.40 million |
| Bioabsorbable Stents Market Size (2022) | US$ 167.7 million |
| Bioabsorbable Stents Market (CAGR 2018 to 2022) | 2.2% |
The bioabsorbable stents market accounts for a negligible share of the global stents market. However, with surging innovations and advancements in bioabsorbable stents, the market is expected to elevate at a steady pace.
As per the latest market records, the market observed a 2.2% CAGR from 2018 to 2022. The Initial generation of stents, called BMS, is composed of cobalt-chromium, tantalum, platinum-iridium alloys, nitinol, and stainless steel. However, these stents have been reworked to alleviate the number of problems or maintenance as a foreign body.
After consideration, coated stents, biodegradable stents, and drug-eluting stents came into the picture. The restenosis rate decreased as bare metal stents saw broader adoption.
Advancements in stents have led to the development of bioabsorbable stents, which can weaken and break down into natural by-products after completing their primary goal of offering judicious support for diseased lesions. Due to quick implantation, the decomposition of bioabsorbable stents is making them reachable to patients of all ages, especially children, boosting the adoption in the next decade.
Due to the widespread frequency of CVD, the demand for bioabsorbable stents is predicted to heighten owing to their efficiency and lowered adverse effects. The bioabsorbable stents market is expected to observe a CAGR of 4% through 2033.
| Country/ Region | Value Share (2022) |
|---|---|
| North America | 48.5% |
| Europe | 27.6% |
| The United States | 44.4% |
| Germany | 9.9% |
| Japan | 5.1% |
The North America market accounted for a sizeable portion of the bioabsorbable stent market in 2022, accounting for 48.5% market share. The United States captures a prominent share in the region, recording a 44.4% value share globally. The market demand for bioabsorbable stents is being influenced not only by doctors, but also by hospital administrators, regulators, and other non-clinicians. This wider circle of influencers presents distinct goals to the table, including cost-effectiveness. This shift in dynamics suggests a change in individual outcomes to an emphasis on population-level usefulness, like an overall enhancement seen in a population for a certain level of spending.
Rivalry in the medical products industry is becoming more intense. Blockbuster categories like bioabsorbable coronary stents are gaining more manufacturers as they mature. As active participants find it harder to identify a high-impact scientific innovation in the market, relatively small firms are procuring market stakes by providing innovative business models at reduced prices. Higher price transparency facilitated by the surging use of tenders in the country is giving a competitive edge to low-cost participants.
Europe is another notable market for bioabsorbable stents. As per the latest market updates, the European bioabsorbable stent market is expected to account for around 27.6% value share in 2023. Germany is predicted to register a chief position in the region. Globally, Germany’s market share is expected to clock 9.9% in 2023. The United Kingdom, which is another key player in the region, is predicted to record a CAGR of 5.7% through 2033.
The region has been an active participant in the field of bioabsorbable stents. The region kickstarted the commercial use of bioresorbable stents by giving appropriate approvals. To be precise, in January 2011, the European CE mark permitted to Absorb, Abbott drug-eluting bioresorbable coronary stent. It was the first-ever bioresorbable stent to obtain regulatory approval the world over.
Fast forward to 2023, the bioresorbable devices still embody the future of coronary stents. Key players in the region are zeroing in on long-term research on the device, with the motive of enhancing the market scope and opportunities for the respective companies. A key example of this practice is Abbott Vascular. With this in mind, companies are expected to thrive in the Europe market.
The Asia Pacific market for bioabsorbable stents paints a promising picture. Core Asian markets like China and India represent a growth of 6.6% and 4.6% CAGR. Consequently, they attract key players to build or expand their base. Surging investments in healthcare and expanding middle classes in these countries are making them a haven for premium products.
Recently, these marketplaces are showing higher growth due to innovations in pricing mechanisms and purchasing processes. Medical product manufacturers in the market have been proactive in capturing the vast opportunities available.
To gain most of the current market scene, key players need to make up their minds about their go-to-market models, tiered portfolios, business development, implications for supply chain, differentiated offerings, M&A, and cost of goods sold. With this comprehensive outlook, they would be better equipped to chart the revenue-generating opportunities in Asia Pacific.
The area of medical research is constantly evolving and currently, it also encompasses bioresorbable stents and polymer-free stents. The Japan bioabsorbable stents industry is being propelled by the increasing acceptability of stents to treat coronary artery disease (CAD). According to the latest research by FMI analysts, the bioabsorbable stents market in Japan is forecast to acquire about 5.1% in 2023.
In the past, precisely in July 2016, Japan’s Ministry of Health, Labor, and Welfare (MHLW) permitted Abbott’s Absorb bioresorbable heart stent, making this then-unique medical instrument commercially available to treat patients of coronary artery disease in Japan.
In the present competitive scene, key players are strategically advancing in the Japan market using M&A, partnerships, collaborations, and product innovation, to gain greater market share.
As per the recent analysis, the Australia market is thriving at a 6.2% CAGR through 2033. Significant untapped prospects in this landscape are fueling the market sales of bioabsorbable stents in the country. By working on improving the insufficiencies of coronary stents, key players can modify these devices to develop an optimized coronary stent. Additionally, the growing knowledge about the enhanced clinical outcomes in interventional cardiology with the use of coronary stents is expected to spur market growth.
Principal Consultant
Coronary artery stents account for a substantial share of 76.2% as of 2022. Numerous angioplasty operations drive demand for coronary stents. Angioplasty can relieve the symptoms of blocked arteries like shortness of breath and chest pains. Due to the high incidence rate of CVD, the selection of angioplasty is fueling the adoption of stent procedures. This is uplifting the demand for coronary artery stents due to their stability and efficacy in comparison to conventional stents.
As per the latest market study, polymer-made bioabsorbable stents are acquiring significant market share in the global landscape. The segment is expected to obtain about 59.3% market share in 2023. Biodegradable (BIO) polymers are capable of reducing the occurrence of subsequent complications like mal-apposition, stent strut uncovering, thrombosis, and endothelial dysfunction. Advantages of using these stents include lowered inflammatory response and entire drug elution. Therefore, polymer materials are gaining significant attention for the development of bioabsorbable stents.
Key players in the market are strategizing to enhance their product range and revise product patenting, to serve the clinical requirements of patients. Market participants release novel products and obtain regulatory approvals and licensing for distribution to improve their geographical presence.
Key Developments in the Market
Key Players in the Market
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The bioabsorbable stents are worth US$ 171.8 million in 2023.
The market is expected to expand at a CAGR of 4% through 2033.
China is expected to see substantial consumption of bioabsorbable stents.
Coronary artery stents are a highly preferred product type by its end users.
Polymers are a sought-after material for bioabsorbable stents.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Stents 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Stents, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Stents, 2023 to 2033 5.3.1. Coronary Artery Stents 5.3.2. Peripheral Artery Stents 5.3.3. Non-vascular Stents 5.3.3.1. Esophageal Stents 5.3.3.2. Billary Stents 5.4. Y-o-Y Growth Trend Analysis By Stents, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Stents, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material, 2023 to 2033 6.3.1. Metallic 6.3.2. Ceramic 6.3.3. Polymers 6.3.3.1. PGA 6.3.3.2. PLA 6.3.3.3. Co-Polymer 6.4. Y-o-Y Growth Trend Analysis By Material, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Material, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033 7.3.1. Cardiovascular 7.3.2. Orthopedics 7.3.3. Cosmetic Surgery 7.3.4. General Surgery 7.3.5. Cranial 7.3.6. Others 7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Specialty Clinics 8.3.3. Ambulatory surgical Centers 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Stents 10.2.3. By Material 10.2.4. By Application 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Stents 10.3.3. By Material 10.3.4. By Application 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Stents 11.2.3. By Material 11.2.4. By Application 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Stents 11.3.3. By Material 11.3.4. By Application 11.3.5. By End User 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Stents 12.2.3. By Material 12.2.4. By Application 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Stents 12.3.3. By Material 12.3.4. By Application 12.3.5. By End User 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Stents 13.2.3. By Material 13.2.4. By Application 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Stents 13.3.3. By Material 13.3.4. By Application 13.3.5. By End User 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Stents 14.2.3. By Material 14.2.4. By Application 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Stents 14.3.3. By Material 14.3.4. By Application 14.3.5. By End User 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Stents 15.2.3. By Material 15.2.4. By Application 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Stents 15.3.3. By Material 15.3.4. By Application 15.3.5. By End User 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Stents 16.2.3. By Material 16.2.4. By Application 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Stents 16.3.3. By Material 16.3.4. By Application 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. U.S. 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Stents 17.1.2.2. By Material 17.1.2.3. By Application 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Stents 17.2.2.2. By Material 17.2.2.3. By Application 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Stents 17.3.2.2. By Material 17.3.2.3. By Application 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Stents 17.4.2.2. By Material 17.4.2.3. By Application 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Stents 17.5.2.2. By Material 17.5.2.3. By Application 17.5.2.4. By End User 17.6. U.K. 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Stents 17.6.2.2. By Material 17.6.2.3. By Application 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Stents 17.7.2.2. By Material 17.7.2.3. By Application 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Stents 17.8.2.2. By Material 17.8.2.3. By Application 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Stents 17.9.2.2. By Material 17.9.2.3. By Application 17.9.2.4. By End User 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Stents 17.10.2.2. By Material 17.10.2.3. By Application 17.10.2.4. By End User 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Stents 17.11.2.2. By Material 17.11.2.3. By Application 17.11.2.4. By End User 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Stents 17.12.2.2. By Material 17.12.2.3. By Application 17.12.2.4. By End User 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Stents 17.13.2.2. By Material 17.13.2.3. By Application 17.13.2.4. By End User 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Stents 17.14.2.2. By Material 17.14.2.3. By Application 17.14.2.4. By End User 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Stents 17.15.2.2. By Material 17.15.2.3. By Application 17.15.2.4. By End User 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Stents 17.16.2.2. By Material 17.16.2.3. By Application 17.16.2.4. By End User 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Stents 17.17.2.2. By Material 17.17.2.3. By Application 17.17.2.4. By End User 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Stents 17.18.2.2. By Material 17.18.2.3. By Application 17.18.2.4. By End User 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Stents 17.19.2.2. By Material 17.19.2.3. By Application 17.19.2.4. By End User 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Stents 17.20.2.2. By Material 17.20.2.3. By Application 17.20.2.4. By End User 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Stents 17.21.2.2. By Material 17.21.2.3. By Application 17.21.2.4. By End User 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Stents 17.22.2.2. By Material 17.22.2.3. By Application 17.22.2.4. By End User 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Stents 17.23.2.2. By Material 17.23.2.3. By Application 17.23.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Stents 18.3.3. By Material 18.3.4. By Application 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Boston Scientific Corporation 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. Meril Life Sciences Pvt. Ltd. 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Medtronic Plc 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. Smith & Nephew Plc 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. Stryker Corporation 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. Wright Medical Group 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. KLS Martin 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. BIOTRONIK Ltd 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. Syntellix AG 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. Q3 Medical Devices Limited. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 19.1.11. JW Medical Systems LTD 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.11.5.2. Product Strategy 19.1.11.5.3. Channel Strategy 19.1.12. ORBUSNEICH MEDICAL 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 19.1.12.5.2. Product Strategy 19.1.12.5.3. Channel Strategy 19.1.13. Abbott Vascular 19.1.13.1. Overview 19.1.13.2. Product Portfolio 19.1.13.3. Profitability by Market Segments 19.1.13.4. Sales Footprint 19.1.13.5. Strategy Overview 19.1.13.5.1. Marketing Strategy 19.1.13.5.2. Product Strategy 19.1.13.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Bioabsorbable Stents Market
